Baicalein induces the transformation of macrophages from M2 type to M1 type and increases the number of M1 phenotypes, and at the same time reduces the tendency of TGF-β to promote tumor expression, thereby inhibiting the activity of breast cancer cells (68). The gene discussed is TGFB1; the disease is neoplasm.